Semaglutide belongs to the same family of medicine
GLP-1 receptor activation is documented to increase resting heart rate through two mechanisms that likely operate in parallel: direct sympathetic nervous system stimulation evidenced by concurrent increases in muscle sympathetic nerve activity measured by microneurography in healthy subjects given exenatide, arguing against reflex tachycardia alone as the explanation and vasodilation of peripheral resistance vessels via cAMP/PKA and nitric oxide pathways, which reduces total peripheral resistance and may recruit baroreflex-driven chronotropy as a secondary effect (Vianna et al., 2012)
The FDA Adverse Event Reporting System Public Dashboard has at least 60 reports of suicidal ideation from people taking semaglutide since 2018
According to FDA labeling, nausea occurs in approximately 44% of patients on Wegovy (2.4 mg for weight management) and 15-20% on lower diabetes doses, with vomiting, diarrhea, constipation, and abdominal pain also common
After months on a GLP-1 medication, dietary habits often drift
/assets/images/provider/photos/2775905.jpeg)
